The Patent Finder

Adverio Pharma GmbH

Also on record
Records under this name other than the patents Adverio Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 27 patents it holds.

Showing 1 to 4 of 4 · Back to Adverio Pharma GmbH

PatentTitleStatus Expires Confidence
US 8,802,847Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,266,885Substituted 5-Fluoro-1H-PYRAZOLOPYRIDINES and Their Use
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,189,856Use of SGC Stimulators, SGC Activators, Alone and Combinations with PDE5 Inhibitors for the Treatment of Systemic Sclerosis (SSC).
Lapsed on the fee record
Ended Jan 29, 2023 · High confidence
Lapsed on the fee recordEnded Jan 29, 2023High confidence
US 6,743,798Substituted Pyrazole Derivatives Condensed with Six-Membered Heterocyclic Rings
Term ended
Term ended Jul 16, 2019 · High confidence
Term endedTerm ended Jul 16, 2019High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited